Skip to content
Boost Up Blog – Lifestyle
Author:
Bryet US Inc
BrYet US, Inc. Files IND Application for ML-016, Lead Oncology Therapeutic for Advanced Solid Tumors with Lung and/or Liver Metastases
March 5, 2026